Karine Le Malicot
Inserm(FR)Inserm(FR)Fédération Francophone de Cancérologie Digestive(FR)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Gastric Cancer Management and Outcomes, Genetic factors in colorectal cancer, Colorectal Cancer Surgical Treatments, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → Prognostic Value ofBRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer(2016)265 cited
- → Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)(2020)164 cited
- → Role of Deficient DNA Mismatch Repair Status in Patients With Stage III Colon Cancer Treated With FOLFOX Adjuvant Chemotherapy(2017)145 cited
- → Prognostic Effect ofBRAFandKRASMutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab(2016)145 cited
- → Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab(2019)136 cited
- → Artificial intelligence-guided tissue analysis combined with immune infiltrate assessment predicts stage III colon cancer outcomes in PETACC08 study